المؤلفون: Wang X; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., Huang N; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., Yip PL; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore., Wang J; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., Huang R; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., Sun Z; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., Kang D; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., He Q; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., Deng X; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China., Zhao C; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China. Electronic address: zhaochong@sysucc.org.cn., Chua MLK; Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore. Electronic address: gmsclkm@nus.edu.sg., Han F; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China. Electronic address: hanfei@sysucc.org.cn.

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 May; Vol. 194, pp. 110154. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/mortality , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Nasopharyngeal Neoplasms*/radiotherapy , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/mortality , Neoplasm Invasiveness*, Humans ; Male ; Female ; Prospective Studies ; Middle Aged ; Adult ; Aged ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Young Adult

المؤلفون: Yip PL; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Zheng H; Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore., Cheo T; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Tan TH; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Lee SF; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Leong YH; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Wong LC; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Tey J; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Ho F; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Soon YY; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.

المصدر: JAMA network open [JAMA Netw Open] 2024 Feb 05; Vol. 7 (2), pp. e2354947. Date of Electronic Publication: 2024 Feb 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Stroke*/epidemiology , Stroke*/etiology , Head and Neck Neoplasms*/epidemiology, Humans ; Male ; Middle Aged ; Aged ; Female ; Australia ; Cross-Sectional Studies ; Survivors

المؤلفون: Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China.; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Yip PL; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China.; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Wo B; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China., Wong NS; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China., Vellayappan BA; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Mamon HJ; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, United States., Lee FAS; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China.

المصدر: Frontiers in oncology [Front Oncol] 2024 Jan 23; Vol. 13, pp. 1284569. Date of Electronic Publication: 2024 Jan 23 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Yip PL; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore 119074, Singapore., You R; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China., Chen MY; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China.; Cooperative Surgical Ward of Nasopharyngeal Carcinoma, Faifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China., Chua MLK; Division of Medical Sciences, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore 168583, Singapore.; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore 168583, Singapore.; Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore 169857, Singapore.

المصدر: Cancers [Cancers (Basel)] 2024 Jan 16; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Neo J; Division of Medical Sciences, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Yip PL; Department of Radiation Oncology, National University Cancer Institute Singapore, 5 Lower Kent Ridge Road, 119074, Singapore., Ong EHW; Division of Medical Sciences, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Miao J; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong 510060, PR China., Chow WM; Division of Medical Sciences, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Wee JTS; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Fong KW; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Soong YL; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Tan TWK; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Tan JSH; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Sin SY; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Liu J; Laboratory of Human Genomics, Genome Institute of Singapore, A Star, 60 Biopolis St, 138672, Singapore; Department of Psychological Medicine, Yong Loo Lin School of Medicine, 10 Medical Dr, 117597, Singapore., Loh KS; Department of Otolaryngology - Head & Neck Surgery, National University of Singapore, 5 Lower Kent Ridge Road, 119074, Singapore; Division of Surgical Oncology, National University Cancer Institute, 5 Lower Kent Ridge Road, 119074, Singapore., Tay JK; Department of Otolaryngology - Head & Neck Surgery, National University of Singapore, 5 Lower Kent Ridge Road, 119074, Singapore; Division of Surgical Oncology, National University Cancer Institute, 5 Lower Kent Ridge Road, 119074, Singapore., Ang MK; Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore., Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore; Oncology Academic Programme, Duke-NUS Medical School, 8 College Road, 169857, Singapore., Lim DWT; Division of Medical Sciences, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore; Oncology Academic Programme, Duke-NUS Medical School, 8 College Road, 169857, Singapore., Chua MLK; Division of Medical Sciences, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore; Division of Radiation Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, 168583, Singapore; Oncology Academic Programme, Duke-NUS Medical School, 8 College Road, 169857, Singapore. Electronic address: gmsclkm@nus.edu.sg.

المصدر: Oral oncology [Oral Oncol] 2024 Jan; Vol. 148, pp. 106655. Date of Electronic Publication: 2023 Dec 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Epstein-Barr Virus Infections*/complications , Nasopharyngeal Neoplasms*/pathology, Humans ; Nasopharyngeal Carcinoma/pathology ; Herpesvirus 4, Human/genetics ; Prognosis ; DNA, Viral ; Recurrence ; Risk Assessment

المؤلفون: Yip PL; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong.; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore., Lee WYV; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong., Leung WK; Auckland Radiation Oncology, Auckland, New Zealand., Nyaw SF; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong., Chan NY; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong., Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong.; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore.

المصدر: Advances in radiation oncology [Adv Radiat Oncol] 2023 Aug 28; Vol. 9 (2), pp. 101363. Date of Electronic Publication: 2023 Aug 28 (Print Publication: 2024).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101677247 Publication Model: eCollection Cited Medium: Print ISSN: 2452-1094 (Print) Linking ISSN: 24521094 NLM ISO Abbreviation: Adv Radiat Oncol Subsets: PubMed not MEDLINE

المؤلفون: Yip PL; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore., Lee AWM; Clinical Oncology Centre, University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Chua MLK; Department of Head and Neck and Thoracic Radiation Oncology and Division of Medical Sciences, National Cancer Centre Singapore 168583, Singapore; Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore. Electronic address: gmsclkm@nus.edu.sg.

المصدر: The Lancet. Oncology [Lancet Oncol] 2023 Jul; Vol. 24 (7), pp. 713-715. Date of Electronic Publication: 2023 Jun 05.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma*/drug therapy , Nasopharyngeal Neoplasms*/drug therapy , Nasopharyngeal Neoplasms*/pathology, Humans ; Nasopharyngeal Carcinoma/drug therapy ; Chemotherapy, Adjuvant ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemoradiotherapy ; Cisplatin/therapeutic use

المؤلفون: Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore. Electronic address: leesf@nuhs.edu.sg., Yip PL; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore. Electronic address: ypl456@ha.org.hk., Chan OL; Department of Radiology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong. Electronic address: col950@ha.org.hk., Lee VWY; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong. Electronic address: lwy174@ha.org.hk., Wong A; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong. Electronic address: wkl053@ha.org.hk., Choi HCW; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; Laboratory of Data Discovery for Health Limited, Hong Kong Science Park, Hong Kong. Electronic address: hcchoi@hku.hk.

المصدر: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 May; Vol. 35 (5), pp. e328-e335. Date of Electronic Publication: 2023 Feb 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: England NLM ID: 9002902 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2981 (Electronic) Linking ISSN: 09366555 NLM ISO Abbreviation: Clin Oncol (R Coll Radiol) Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery*/methods , Brain Neoplasms*/secondary, Humans ; Treatment Outcome ; Brain/pathology ; Prognosis ; Retrospective Studies

المؤلفون: Yip PL; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China.; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore., Fung WHB; Department of Radiology and Nuclear Medicine, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China., Lee FAS; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China., Lee CF; Department of Pharmacy, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China., Wong NSM; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China., Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, Hong Kong SAR, China.; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.

المصدر: Frontiers in oncology [Front Oncol] 2023 Apr 06; Vol. 13, pp. 1138357. Date of Electronic Publication: 2023 Apr 06 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong West Cluster, Hospital Authority, Hong Kong, China.; Department of Radiation Oncology, National University Cancer Institute, Singapore., Yip PL; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, China., Vellayappan BA; Department of Radiation Oncology, National University Cancer Institute, Singapore., Chee CE; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Wong LC; Department of Radiation Oncology, National University Cancer Institute, Singapore., Wan EY; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Sha Tin, Hong Kong, China.; Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Sha Tin, Hong Kong, China.; The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, China.; Department of Pharmacy, University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Lee CF; Department of Pharmacy, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, China.; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China., Lee FA; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, China., Luque-Fernandez MA; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Inequalities in Cancer Outcomes Network, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Department of Non-Communicable Disease and Cancer Epidemiology, Instituto de Investigacion Biosanitaria de Granada, Granada, Spain.; Cancer Registry of Granada, Andalusian School of Public Health, Granada, Spain; and.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBER of Epidemiology and Public Health, CIBERESP), Madrid, Spain.

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 Oct; Vol. 20 (10), pp. 1125-1133.e10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/etiology , Colorectal Neoplasms*/complications , Colorectal Neoplasms*/epidemiology , Colorectal Neoplasms*/therapy, Adult ; Aged ; Cohort Studies ; Humans ; Incidence ; Male ; Risk Factors ; Survivors